Category: Press Release - Psilocybin Alpha

Psyched Wellness Becomes Latest Psychedelics Company to Go Public (CSE: PSYC)

Psyched Wellness Becomes Latest Psychedelics Company to Go Public (CSE: PSYC)

Post published:October 21, 2020
Post category:Press Release

Media Company Delic Corp. Announces RTO, Becomes Latest Psychedelics Company Planning to Go Public

Media Company Delic Corp. Announces RTO, Becomes Latest Psychedelics Company Planning to Go Public

Post published:October 21, 2020
Post category:Press Release

Mind Cure Announces LOI for Acquisition of Epiphany360 Digital Therapeutics Platform for Treating Mental Health

Mind Cure Announces LOI for Acquisition of Epiphany360 Digital Therapeutics Platform for Treating Mental Health

Post published:October 21, 2020
Post category:Press Release

Ehave Expands Its Psychedelic Mental Health Platform with Medchart, a Leader in Medical Record Software, as a Plugin to the Ehave Dashboard

Ehave Expands Its Psychedelic Mental Health Platform with Medchart, a Leader in Medical Record Software, as a Plugin to the Ehave Dashboard

Post published:October 20, 2020
Post category:Press Release

NeonMind Superfood Mushroom Coffee Update

NeonMind Superfood Mushroom Coffee Update

Post published:October 20, 2020
Post category:Press Release

Pharmather Files for FDA Orphan Drug Designation for Ketamine in Parkinson’s Disease

Pharmather Files for FDA Orphan Drug Designation for Ketamine in Parkinson’s Disease

Post published:October 20, 2020
Post category:Press Release

Revive Therapeutics Signs Supply Agreement With Havn Life Sciences for Psychedelic Compounds

Revive Therapeutics Signs Supply Agreement With Havn Life Sciences for Psychedelic Compounds

Post published:October 20, 2020
Post category:Press Release

Cybin Raises $45 Million, Inches Closer to NEO Listing

Cybin Raises $45 Million, Inches Closer to NEO Listing

Post published:October 19, 2020
Post category:Press Release

Mind Medicine MindMed : MindMed Files Preliminary Prospectus In Connection With Bought Deal Equity Financing

Mind Medicine MindMed : MindMed Files Preliminary Prospectus In Connection With Bought Deal Equity Financing

Post published:October 16, 2020
Post category:Press Release

Mydecine Innovations Group Appoints Boustead Capital Markets LLP as Financial Advisor for its Planned Dual Listing on the London Stock Exchange

Mydecine Innovations Group Appoints Boustead Capital Markets LLP as Financial Advisor for its Planned Dual Listing on the London Stock Exchange

Post published:October 16, 2020
Post category:Press Release

End of content

No more pages to load

The definitive resource for investors in the emergent psychedelic medicine sector. Cut through the shroom stock noise with exclusive news, interviews, data and private financing opportunities.

Quick Links

Shroom Stocks and Companies

News & Interviews

Data Bank

Get in Touch

Newsletter

Industry insights and interviews delivered to your inbox. No spam, just valuable information.

Contact Disclaimer Terms of Service Privacy Policy Twitter

© Psilocybin Alpha 2020